Literature DB >> 18923413

CD4 immunophenotyping in HIV infection.

David Barnett1, Brooke Walker, Alan Landay, Thomas N Denny.   

Abstract

The ability to rapidly identify immune cell subsets such as CD4 cells, which became possible around the same time as the onset of the HIV/AIDS pandemic, was one of the greatest advances in clinical and diagnostic immunology. The evolution of this global pandemic and the subsequent development of treatment strategies to prolong the life of infected individuals mean that it is now more crucial than ever that we develop affordable, reliable and accurate methods for the enumeration of CD4 cells. Here, we provide an overview of the historical developments in CD4 enumeration technologies that are related to HIV infection, and summarize the current technological challenges that must be overcome to meet the needs of those living with HIV infection.

Entities:  

Mesh:

Year:  2008        PMID: 18923413      PMCID: PMC2728050          DOI: 10.1038/nrmicro1998

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  76 in total

Review 1.  Adoption of single-platform technologies for enumeration of absolute T-lymphocyte subsets in peripheral blood.

Authors:  M R O'Gorman; J K Nicholson
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Dissociation of immunologic and virologic responses to highly active antiretroviral therapy.

Authors:  W J Fessel; J F Krowka; H W Sheppard; M Gesner; S Tongson; S Weinstein; M Ascher; S Kwok; C Christopherson
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

Review 3.  British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

Authors:  B Gazzard; A J Bernard; M Boffito; D Churchill; S Edwards; N Fisher; A M Geretti; M Johnson; C Leen; B Peters; A Pozniak; J Ross; J Walsh; E Wilkins; M Youle
Journal:  HIV Med       Date:  2006-11       Impact factor: 3.180

4.  A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study.

Authors:  Thomas N Denny; Rebecca Gelman; Michele Bergeron; Alan Landay; Lee Lam; Raul Louzao; Frank F Mandy; John Schmitz; Thomas Spira; Cindy Wilkening; Deborah K Glencross
Journal:  Cytometry B Clin Cytom       Date:  2008       Impact factor: 3.058

5.  New developments in the biology and treatment of HIV.

Authors:  F Bushman; N R Landau; E A Emini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

6.  1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-01-10

7.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

8.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; Jose M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; Stefano Vella; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

9.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

10.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

View more
  25 in total

1.  Reference ranges for lymphocyte subsets among healthy Hong Kong Chinese adults by single-platform flow cytometry.

Authors:  W S Wong; A W I Lo; L P Siu; J N S Leung; S P Tu; S W Tai; S C Lam; K F Wong
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

Review 2.  Review of methods to probe single cell metabolism and bioenergetics.

Authors:  Andreas E Vasdekis; Gregory Stephanopoulos
Journal:  Metab Eng       Date:  2014-10-31       Impact factor: 9.783

3.  Time and temperature stability of T-cell subsets evaluated by a dual-platform method.

Authors:  Horatiu Olteanu; Bernard C Schur; Alexandra M Harrington; Steven H Kroft
Journal:  Am J Blood Res       Date:  2012-05-25

4.  Fast sorting of CD4+ T cells from whole blood using glass microbubbles.

Authors:  Chia-Hsien Hsu; Chihchen Chen; Daniel Irimia; Mehmet Toner
Journal:  Technology (Singap World Sci)       Date:  2015-03

5.  VERITAS?: A time for VERIQAS™ and a new approach to training, education, and the quality assessment of CD4+ T lymphocyte counting (I).

Authors:  David Barnett; Liam Whitby; John Wong; Raul Louzao; John T Reilly; Thomas N Denny
Journal:  Cytometry B Clin Cytom       Date:  2011-10-13       Impact factor: 3.058

6.  The Association Between Peripheral Oxytocin Levels and Depressive Symptoms in People With HIV.

Authors:  Destin D Shortell; Leah H Rubin; Aidan J Murphy; Ronald A Cohen; Eric C Porges
Journal:  Psychosom Med       Date:  2022-08-16       Impact factor: 3.864

7.  A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey.

Authors:  Jonathan M Kagan; Ana M Sanchez; Alan Landay; Thomas N Denny
Journal:  For Immunopathol Dis Therap       Date:  2015

Review 8.  New approaches to understanding the immune response to vaccination and infection.

Authors:  David Furman; Mark M Davis
Journal:  Vaccine       Date:  2015-07-29       Impact factor: 3.641

9.  T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-beta genes.

Authors:  Andrew D Redd; Emily J Ciccone; Gertrude Nakigozi; Jeanne C Keruly; Anthony Ndyanabo; Boaz Iga; Ronald H Gray; David Serwadda; Thomas C Quinn
Journal:  J Immunol Methods       Date:  2010-01-28       Impact factor: 2.303

10.  Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma.

Authors:  V R M Lombardi; E Martínez; R Chacón; I Etcheverría; R Cacabelos
Journal:  J Biomed Biotechnol       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.